Summary
Eli Lilly and Company (LLY) filed an 8-K on November 6, 2018, to announce its third quarter and three-month period results for the period ended September 30, 2018. The filing primarily consists of a press release (Exhibit 99.1) detailing these operational and financial outcomes, which are being furnished and not formally filed under Section 18 of the Exchange Act. Investors should refer to Exhibit 99.1 for the specific financial details and performance metrics of the quarter. This report serves as the official notification of the company's most recent financial performance. While the 8-K itself is brief, it directs stakeholders to the attached press release for a comprehensive overview of the company's third-quarter results, including unaudited operating results. Investors interested in the company's financial health, revenue streams, and profitability for the period should examine the content of the press release.
Key Highlights
- 1Eli Lilly & Co. (LLY) filed an 8-K on November 6, 2018.
- 2The report announces the company's results for the third quarter and three-month period ended September 30, 2018.
- 3The primary information is contained within Exhibit 99.1, a press release dated November 6, 2018.
- 4The press release provides unaudited operating results for the specified period.
- 5Information is furnished and not deemed 'filed' for purposes of Section 18 of the Exchange Act.
- 6The filing incorporates the press release by reference into Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits).